Navigation Links
Scientists Spot Key to Breast Cancer Spread
Date:9/11/2009

Combination of proteins sparks disease growth, research shows

FRIDAY, Sept. 11 (HealthDay News) -- Too much of two proteins can send noninvasive breast cancer into a deadly spread through the body, researchers say.

In a study at the University of Texas M.D. Anderson Cancer Center in Houston, scientists found that the overproduction of the protein 14-3-3 zeta, when combined with the known breast cancer protein ErbB2, or HER2, can change premalignant epithelial cells into mobile mesenchymal-like cells. The resulting process, known as epithelial-to-mesenchymal transition, triggers cancer spread from one site in the body to another.

"We have discovered a key molecular mechanism for the deadly transition of non-invasive breast cancer into invasive disease," senior author Dr. Dihua Yu, professor in the center's department of molecular and cellular oncology, said in a news release issued by the university.

Cancer involving the two proteins may also be more deadly, based on the findings published in the Sept. 9 issue of Cancer Cell.

In one experiment, the researchers injected a breast cancer cell line with the two overexpressed proteins into mice, resulting in these mice having three times the metastasis, or cancer spread, as mice given a different cancer cell line.

The researchers also found that of 107 human cases of invasive breast cancer they studied, a little more than 20 percent involved cancers that overexpressed both proteins, and these patients did not live as long as those whose tumors produced one or neither of the proteins.

However, the researchers identified a biomarker in 14-3-3 zeta that may help doctors identify these high-risk patients so that more aggressive treatment can be given before the breast cancer has a chance to convert to an invasive kind.

The findings may have far-reaching implications. Yu and her team had previously found that lung, liver, uterine, stomach and several other cancers also overproduce the 14-3-3 zeta protein.

More information

The U.S. National Cancer Institute has more about breast cancer.



-- Kevin McKeever



SOURCE: University of Texas M.D. Anderson Cancer Center, news release, Sept. 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Find Clue to Dangerous Side Effect of MS Drug
2. Scientists Spot Clue to Cancers Aggressiveness
3. Scientists Turn Off Obesity Switch in Mice
4. NIBIB scientists increase imaging efficiency in cell structure studies
5. Scientists Make Sweet Monkey Music
6. Scientists from University of Hawaii at Manoa find genetic marker
7. Nottingham scientists commissioned for urgent swine flu research
8. Ellison Medical Foundation awards more than $1 million to mid-career scientists
9. New Federal Training Grant to Teach Doctors/Scientists Immunology
10. Scientists Spot How Sugar Feeds Tumors
11. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Spot Key to Breast Cancer Spread
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: